<--- Back to Details
First PageDocument Content
Haemophilia / Biotechnology / Molecular biology / Genetics / Gene therapy / Prion / Transmissible spongiform encephalopathy / Sickle-cell disease / Factor IX / Biology / Medicine / Coagulation system
Date: 2014-01-30 12:15:57
Haemophilia
Biotechnology
Molecular biology
Genetics
Gene therapy
Prion
Transmissible spongiform encephalopathy
Sickle-cell disease
Factor IX
Biology
Medicine
Coagulation system

Microsoft Word - Abstract_Vol_2_1a_.doc

Add to Reading List

Source URL: www.hema-quebec.qc.ca

Download Document from Source Website

File Size: 58,33 KB

Share Document on Facebook

Similar Documents

Large ElectronPositron Collider

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document